Daniel Eiger
Daniel Eiger, MD, is a Brazilian clinical oncologist and former ESMO Fellow in clinical research (focus on cardiotoxicity of anti-HER2 agents) and fellow at Institut Jules Bordet in Brussels, Belgium until September 2020.
Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
Daniel Eiger, MD, is a Brazilian clinical oncologist and former ESMO Fellow in clinical research (focus on cardiotoxicity of anti-HER2 agents) and fellow at Institut Jules Bordet in Brussels, Belgium until September 2020.
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.